Kitzen JM[au] - Search Results

Year	Number of Results
1976	1
1977	1
1978	2
1979	1
1980	1
1982	1
1983	1
1984	1
1987	1
1988	5
1989	2
1990	1
1991	3
1992	3
1993	1
1999	1
2018	1
2019	2
2023	0

1

e-Cigarettes for smoking cessation: Do they deliver?

Kitzen JM, McConaha JL, Bookser ML, Pergolizzi JV Jr, Taylor R Jr, Raffa RB. Kitzen JM, et al. J Clin Pharm Ther. 2019 Aug;44(4):650-655. doi: 10.1111/jcpt.12833. Epub 2019 Apr 4. J Clin Pharm Ther. 2019. PMID: 30950094 Clinical Trial.

2

Sunscreen bans: Coral reefs and skin cancer.

Raffa RB, Pergolizzi JV Jr, Taylor R Jr, Kitzen JM; NEMA Research Group. Raffa RB, et al. Among authors: kitzen jm. J Clin Pharm Ther. 2019 Feb;44(1):134-139. doi: 10.1111/jcpt.12778. Epub 2018 Nov 28. J Clin Pharm Ther. 2019. PMID: 30484882

3

Vasodilator activity of adenosine analogs.

Gangjee A, Hogenkamp HP, Kitzen JM. Gangjee A, et al. Among authors: kitzen jm. J Pharm Sci. 1978 Jan;67(1):121-3. doi: 10.1002/jps.2600670134. J Pharm Sci. 1978. PMID: 619101

4

Alpha-adrenergic activity of N,N-dimethyldopamine (DMDA).

Kitzen JM, Ilhan M, Cannon JG, Long JP. Kitzen JM, et al. Eur J Pharmacol. 1976 Aug;38(2):365-72. doi: 10.1016/0014-2999(76)90341-1. Eur J Pharmacol. 1976. PMID: 8321

5

2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,4'-piperidine]s and 2,3-dihydro-3-(1-pyrryl)spiro[benzofuran-2,3'-pyrrolidine]s: novel antihypertensive agents.

Davis L, Agnew MN, Effland RC, Klein JT, Kitzen JM, Schwenkler MA. Davis L, et al. Among authors: kitzen jm. J Med Chem. 1983 Oct;26(10):1505-10. doi: 10.1021/jm00364a027. J Med Chem. 1983. PMID: 6620309

6

The effects of two analogs of dopamine on ganglionic transmission in the sympathetic nervous system.

Kitzen JM, Strait MR, Long JP, De Groat WC. Kitzen JM, et al. J Pharmacol Exp Ther. 1979 Dec;211(3):519-24. J Pharmacol Exp Ther. 1979. PMID: 229210

7

Cardiac electrophysiologic and hemodynamic activity of pimobendan (UD-CG 115 BS), a new inotropic agent.

Kitzen JM, Lynch JJ, Driscoll EM, Lucchesi BR. Kitzen JM, et al. J Pharmacol Exp Ther. 1988 Mar;244(3):929-39. J Pharmacol Exp Ther. 1988. PMID: 3252039

8

Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.

Lynch JJ, Kitzen JM, Hoff PT, Lucchesi BR. Lynch JJ, et al. Among authors: kitzen jm. J Cardiovasc Pharmacol. 1988;12(5):547-54. doi: 10.1097/00005344-198811000-00008. J Cardiovasc Pharmacol. 1988. PMID: 2468054

9

Effects of the positive inotropic agents milrinone and pimobendan on the development of lethal ischemic arrhythmias in conscious dogs with recent myocardial infarction.

Lynch JJ Jr, Uprichard AC, Frye JW, Driscoll EM, Kitzen JM, Lucchesi BR. Lynch JJ Jr, et al. Among authors: kitzen jm. J Cardiovasc Pharmacol. 1989 Oct;14(4):585-97. doi: 10.1097/00005344-198910000-00010. J Cardiovasc Pharmacol. 1989. PMID: 2478772

10

Pharmacology of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99). I. Cardiovascular activity in the dog and cat.

Kitzen JM, Long JP, Cannon JG. Kitzen JM, et al. J Pharmacol Exp Ther. 1978 Aug;206(2):239-47. J Pharmacol Exp Ther. 1978. PMID: 28414

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results